Masaru Matsuda
CIK: 0001798679
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Arcutis Biotherapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (31 total)
- Sep 16, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct3.7K shares at avg. $25.00$92K - Sep 8, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct10K shares at avg. $25.03$250K - Aug 3, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct1.2K shares at avg. $26.12$32K - May 4, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct884 shares at avg. $23.61$21K - May 4, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct7.4K shares at avg. $23.27$172K - Mar 2, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct6.6K shares at avg. $25.16$165K - Mar 2, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct193 shares at avg. $25.91$5K - Mar 2, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct2K shares at avg. $25.70$51K - Feb 27, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct3.3K shares at avg. $27.95$93K - Feb 27, 2026ARQT
Arcutis Biotherapeutics, Inc.
Award(A)Direct37K shares- - Feb 2, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct4.7K shares at avg. $25.63$121K - Feb 2, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct8.6K shares at avg. $24.97$214K - Feb 2, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct8K shares at avg. $25.50$204K - Feb 2, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct19.4K shares at avg. $25.24$489K - Dec 1, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct1.7K shares at avg. $30.23$50K - Nov 19, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct989 shares at avg. $27.95$28K - Nov 19, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct1.6K shares at avg. $28.50$44K - Nov 3, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct7.2K shares at avg. $24.71$177K - Nov 3, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct43 shares at avg. $25.40$1K - Sep 4, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct36.1K shares at avg. $16.16$584K - Aug 4, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct6.3K shares at avg. $14.33$91K - May 28, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct1.8K shares at avg. $13.78$25K - May 2, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct5K shares at avg. $15.20$76K - Mar 3, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct3.3K shares at avg. $13.03$43K - Feb 28, 2025ARQT
Arcutis Biotherapeutics, Inc.
Award(A)Direct34K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 3,674 | $25.00 | $91,853 | Direct |
| Sep 8, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 9,989 | $25.03 | $249,986 | Direct |
| Aug 3, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 1,230 | $26.12 | $32,124 | Direct |
| May 4, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 884 | $23.61 | $20,872 | Direct |
| May 4, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 7,372 | $23.27 | $171,543 | Direct |
| Mar 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 6,553 | $25.16 | $164,876 | Direct |
| Mar 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 193 | $25.91 | $5,001 | Direct |
| Mar 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 1,987 | $25.70 | $51,066 | Direct |
| Feb 27, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 3,325 | $27.95 | $92,934 | Direct |
| Feb 27, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Award(A) | 37,000 | - | $0 | Direct |
| Feb 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 4,714 | $25.63 | $120,820 | Direct |
| Feb 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 8,562 | $24.97 | $213,793 | Direct |
| Feb 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 7,983 | $25.50 | $203,554 | Direct |
| Feb 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 19,379 | $25.24 | $489,126 | Direct |
| Dec 1, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 1,657 | $30.23 | $50,091 | Direct |
| Nov 19, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 989 | $27.95 | $27,647 | Direct |
| Nov 19, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 1,561 | $28.50 | $44,489 | Direct |
| Nov 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 7,165 | $24.71 | $177,064 | Direct |
| Nov 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 43 | $25.40 | $1,092 | Direct |
| Sep 4, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 36,130 | $16.16 | $583,716 | Direct |
| Aug 4, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 6,330 | $14.33 | $90,687 | Direct |
| May 28, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 1,800 | $13.78 | $24,807 | Direct |
| May 2, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 5,030 | $15.20 | $76,453 | Direct |
| Mar 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 3,263 | $13.03 | $42,520 | Direct |
| Feb 28, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Award(A) | 34,000 | - | - | Direct |
1-25 of 31 transactions
About Matsuda Masaru
Matsuda Masaru (SEC CIK 0001798679) files insider reports with the SEC as Officer of Arcutis Biotherapeutics, Inc. (ARQT).
Signal8 holds 18 ownership filings by Matsuda Masaru, all Form 4s, filed between Nov 5, 2024 and Sep 18, 2026. Those filings report 31 transactions, from May 31, 2024 to Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Matsuda Masaru's filings is in WESTLAKE VILLAGE, CA.
Recent filings by Matsuda Masaru
- Sep 16, 2026: Open-market sale of ARQT shares (Form 4, code S).
- Sep 8, 2026: Open-market sale of ARQT shares (Form 4, code S).
- Aug 3, 2026: Open-market sale of ARQT shares (Form 4, code S).
- May 4, 2026: Open-market sales of ARQT shares (2 lines, Form 4, code S).
- Mar 2, 2026: Open-market sales of ARQT shares (3 lines, Form 4, code S).
Other insiders filing for Arcutis Biotherapeutics, Inc. (ARQT)
- SCOTT ROBERT A, Director
- Welgus Howard G., Director
- Curran Terrie, Director
- Burnett Patrick
- Watanabe Todd
- Peetz Christopher, Director